Philadelphia, PA – According to filings with the U.S. Securities and Exchange Commission, Vitara Biomedical is raising $74,993,216.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, James Mcglone played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Vitara Biomedical
Vitara is developing a therapeutic platform to support premature infants. Our innovative platform is inspired by natural physiological processes and hopes to transform neonatal care. Our goal is to protect more preterm infants and improve their quality of life by reducing mortality and comorbidities.

To learn more about Vitara Biomedical, visit http://www.vitara.com/

Contact:
James Mcglone, President and Chief Executive Officer
267-518-6300
mcglonej@vitara.com
https://www.linkedin.com/in/jim-mcglone/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved